Psilocybin for Elderly

(Psil-Pk Trial)

This trial investigates the safety of psilocybin, a psychedelic substance, in healthy older adults. Researchers aim to assess how well adults aged 65-85 tolerate psilocybin when given in two increasing doses 30 days apart. The trial seeks participants who are generally healthy and have a support person available if needed. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative treatment.

The trial requires that you stop taking certain medications, including those that affect serotonin in the brain, antipsychotics, some mood stabilizers, and specific enzyme inhibitors. If you're on any of these, you may need to stop them before participating.

Research shows that psilocybin is generally safe and well-tolerated in older adults when used in controlled settings. Studies have found few serious side effects, and most people don't experience major issues. A review of clinical trials suggests that psilocybin can be safe for healthy older adults. Previous studies on older individuals have shown promising results for safety and tolerance.¹²³⁴⁵

Unlike the standard of care for elderly patients, which often includes antidepressants or anxiolytics, psilocybin offers a unique approach by utilizing a psychedelic compound found in certain mushrooms. Researchers are excited about psilocybin because it has the potential to rapidly reduce symptoms of depression and anxiety, often with just one or two doses, whereas traditional medications can take weeks to show effects. Additionally, psilocybin targets serotonin receptors in a novel way, potentially leading to long-lasting changes in mood and cognition, which is a promising alternative to the ongoing use of conventional medications.

Research has shown that psilocybin, a compound in certain mushrooms, may improve mental health issues like depression and anxiety, especially with psychological support. For older adults, studies have observed improved mood and overall well-being. One study suggested that psilocybin might slow aging by affecting cellular function. Another study highlighted its potential to extend cell life and boost brain function. While more research is needed, these findings suggest psilocybin could enhance the quality of life for older adults. Participants in this trial will receive two escalating doses of psilocybin, 30 days apart, to further explore these potential benefits.¹⁶⁷⁸⁹